Tiziana Vavala

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Knowledge of menopause-associated symptoms and non-hormonal strategies: an Italian survey on social media platforms.

Knowledge of menopause-associated symptoms and non-hormonal strategies: an Italian survey on social media platforms.

Journal: Post reproductive health

Published: July 06, 2026

Sex and gender-oriented colorectal cancer screening: a consensus study from the AIOM- GISEG working group.

Sex and gender-oriented colorectal cancer screening: a consensus study from the AIOM- GISEG working group.

Journal: Frontiers in oncology

Published: March 26, 2026

EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the 'Rebiopsy on osi' Study).

EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the 'Rebiopsy on osi' Study).

Journal: The oncologist

Published: February 11, 2026

Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing.

Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 18, 2026

Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry.

Journal: Cancer

Published: December 16, 2025

Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥ 50%: real-world data from the Italian ATLAS registry.

Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥ 50%: real-world data from the Italian ATLAS registry.

Journal: The oncologist

Published: September 19, 2025

Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.

Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 16, 2025

Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database.

Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 02, 2025

Immunotherapy outcomes in non-small cell lung cancer according to a gender perspective.

Immunotherapy outcomes in non-small cell lung cancer according to a gender perspective.

Journal: Progress in molecular biology and translational science

Published: October 26, 2024

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM).

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM).

Journal: ESMO open

Published: October 30, 2023

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program.

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 27, 2023

Editorial: Brain and leptomeningeal metastases in lung cancer.

Editorial: Brain and leptomeningeal metastases in lung cancer.

Journal: Frontiers in oncology

Published: December 03, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026